One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
An RX mirror and its underlying label are not independent clinical confirmations.
The no-adjustment statement applies to the renal range studied, not to severe impairment or end-stage disease.
What to reconcile: Keep indexed eGFR units and the unstudied population warning attached to the answer.
Open this note and its source referencesThe previously unavailable RX renal passage is now retained. Its eGFR range and severe/ESRD gap agree with the selected official passage, but share a label lineage.
What to reconcile: Use indexed eGFR as printed and keep severe impairment and dialysis as open evidence limits.
Open this note and its source referencesConfirm the exact product, indication, renal measure, kidney trend and dialysis modality.
The RX destination returned an access failure in this pass. This primary-label addition is not an RX-page recovery.
| Renal setting / scope | Source-specific action and limits |
|---|---|
| eGFR >=30 to <90 mL/min/1.73 m2 | No renal dose adjustment is needed. |
| Severe renal impairment or end-stage renal disease | Not studied. Do not extrapolate the above statement to these groups or dialysis. |
| Renal setting / scope | Source-specific action and limits |
|---|---|
| eGFR >=30 to <90 mL/min/1.73 m2 | No renal dose adjustment is needed. |
| Severe renal impairment or end-stage renal disease | Not studied. Do not extrapolate the above statement to these groups or dialysis. |
The RX destination returned an access failure in this pass. This primary-label addition is not an RX-page recovery.
RDM70-eplontersen-wainua-63cc94f37d · Source locator: Sections 8.6 and 12.3
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=eplontersen-wainua&s1=RDM70-eplontersen-wainua-label&h1=b5525e4209d96e0bb29ca4bad65f7e090770422fc7c9ba993fe672e4e16bb26a